Yeast (1,3)-(1,6)-beta-glucan helps to maintain the body’s defence against pathogens: a double-blind, randomized, placebo-controlled, multicentric study in healthy subjects

被引：0
|
作者：
Annegret Auinger
Linda Riede
Gordana Bothe
Regina Busch
Joerg Gruenwald
机构：
[1] analyze & realize ag,
来源：
European Journal of Nutrition | 2013年 / 52卷
关键词：
Randomized; Placebo-controlled; Double-blind study; Insoluble yeast beta-glucan; Common cold; Immune system;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1913 / 1918
页数：5
相关论文
共 50 条
  • [1] Yeast (1,3)-(1,6)-beta-glucan helps to maintain the body's defence against pathogens: a double-blind, randomized, placebo-controlled, multicentric study in healthy subjects
    Auinger, Annegret
    Riede, Linda
    Bothe, Gordana
    Busch, Regina
    Gruenwald, Joerg
    EUROPEAN JOURNAL OF NUTRITION, 2013, 52 (08) : 1913 - 1918
  • [2] Effects of Yeast (1,3)-(1,6)-Beta-Glucan on Severity of Upper Respiratory Tract Infections: A Double-Blind, Randomized, Placebo-Controlled Study in Healthy Subjects
    Dharsono, Tanita
    Rudnicka, Karolina
    Wilhelm, Manfred
    Schoen, Christiane
    JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 2019, 38 (01) : 40 - 50
  • [3] Two randomized, double-blind, placebo-controlled, dose-escalation phase 1 studies evaluating BTH1677, a 1, 3–1,6 beta glucan pathogen associated molecular pattern, in healthy volunteer subjects
    C. E. Halstenson
    T. Shamp
    M. A. Gargano
    R. M. Walsh
    M. L. Patchen
    Investigational New Drugs, 2016, 34 : 202 - 215
  • [4] SAFETY OF AMISELIMOD IN HEALTHY SUBJECTS: RESULTS FROM A PHASE 1 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Hanauer, Stephen
    O'Reilly, Terry
    Lester, Robert
    Slatkin, Neal
    Lee, Jimin
    Franklin, Howard
    Bulawski, Angela
    Israel, Robert
    INFLAMMATORY BOWEL DISEASES, 2021, 27 : S1 - S1
  • [5] SAFETY OF AMISELIMOD IN HEALTHY SUBJECTS: RESULTS FROM A PHASE 1 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Hanauer, Stephen
    O'Reilly, Terry
    Lester, Robert
    Slatkin, Neal
    Lee, Jimin
    Franklin, Howard
    Bulawski, Angela
    Israel, Robert
    GASTROENTEROLOGY, 2021, 160 (03) : S1 - S2
  • [6] Two randomized, double-blind, placebo-controlled, dose-escalation phase 1 studies evaluating BTH1677, a 1, 3-1,6 beta glucan pathogen associated molecular pattern, in healthy volunteer subjects
    Halstenson, C. E.
    Shamp, T.
    Gargano, M. A.
    Walsh, R. M.
    Patchen, M. L.
    INVESTIGATIONAL NEW DRUGS, 2016, 34 (02) : 202 - 215
  • [7] AMAGINE-1: a phase 3, randomized, double-blind, placebo-controlled study of brodalumab in subjects with psoriasis
    Papp, K.
    Reich, K.
    Leonardi, C.
    Paul, C.
    Blauvelt, A.
    Baran, W.
    Bolduc, C.
    Toth, D.
    Langley, R. G.
    Cather, J.
    Gottlieb, A. B.
    Thaci, D.
    Milmont, C. E.
    Li, J.
    Klekotka, P.
    Kricorian, G.
    Nirula, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (06) : E119 - E120
  • [8] SHR-1918, a monoclonal antibody against angiopoietin-like 3, in healthy subjects: a randomized, double-blind, placebo-controlled, phase 1 study
    Xie, Z.
    Ye, L.
    Hu, W.
    Lv, C.
    Zhu, M.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [9] SHR-1918, a monoclonal antibody against angiopoietin-like 3, in healthy subjects: a randomized, double-blind, placebo-controlled, phase 1 study
    Xie, Z.
    Ye, L.
    Hu, W.
    Lv, C.
    Zhu, M.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [10] Macrophage stimulating agent soluble yeast β-1,3/1,6-glucan as a topical treatment of diabetic foot and leg ulcers: A randomized, double blind, placebo-controlled phase II study
    Zykova, Svetlana N.
    Balandina, Ksenia A.
    Vorokhobina, Natalia V.
    Kuznetsova, Alla V.
    Engstad, Rolf
    Zykova, Tatiana A.
    JOURNAL OF DIABETES INVESTIGATION, 2014, 5 (04): : 392 - 399
12345